There are always a number of clinical trials underway in New Zealand for people with skin disease. These not only provide valuable information on better ways to treat skin disease, but also can give doctors and patients in New Zealand access to newer treatments that we might otherwise not get for many years due to limited funding.
The following is a list of trials that are underway at dermatology trial centres. If you are a patient or a doctor wanting to find out more about a trial, please contact the trial centres directly.
Trials for patients with Eczema
- A phase 1b randomized, double-blind, placebo-controlled, 3-part study to investigate the safety, pharmacokinetics, and pharmacodynamics of single and multiple subcutaneous doses of a new medication targeting T regulatory cell function for eczema in adults with moderate-to-severe atopic dermatitis. Recruiting now.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105
- A phase 3, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of a new IL-2 agonist for patients ≥ 12 Years of age with moderate-to-severe atopic dermatitis. Recruiting soon.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105
- A phase 2b, multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of a new monoclonal antibody targeting OX40 for eczema in adults with moderate-to-severe atopic dermatitis. Recruiting soon.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105
Dermatology Department, Greenlane Clinical Centre (Epsom, AUCKLAND).
Contact email: susan.francis@tewhatuora.govt.nz telephone: 021 241 9284
Trials for patients with Alopecia Areata
- A phase 3 randomized, placebo-controlled, double-blind study to evaluate efficacy and safety of upadacitinib in paediatric subjects with alopecia areata. Recruiting soon.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105
Dermatology Department, Greenlane Clinical Centre (Epsom, AUCKLAND)
(16 and 17 years olds ONLY)
Contact email: susan.francis@tewhatuora.govt.nz telephone: 021 241 9284
Trials for patients with Vitiligo
- A phase 3, randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety, and tolerability of upadacitinib in paediatric patients with vitiligo. Recruiting soon.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105
Trials for patients with Hidradenitis Suppurativa
- A phase 3 randomized, placebo-controlled, double-blind study to evaluate efficacy and safety of updacitinib in adults and adolescents with moderate to severe hidradenitis suppurativa who have failed anti-TNF therapy. Recruitment closed.
Clinical Trials New Zealand (HAMILTON)
Contact email: info@clinicaltrialsnz.com telephone: 07 843 0105